This is the second in a 3-part series on ”The Challenges of Patient Recruitment in Oncology Trials”, Senior Patient Recruitment Managers Tricia Buchheit and Lauren Johnson explore the common misconceptions which hinder patient recruitment in oncology trials and how combat and reassure patients with these reservations regarding clinical research.
Translating Cancer Genomics Into a Personalized Approach For Cancer Patients
This white paper provides a brief history of oncology genomics, including development, uses in improving patient care, current achievements and…
Our in-house oncology and hematology experts make the complex, simple. Our
The Challenges of Patient Recruitment in Oncology Trials - Part 3
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…